Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Illinois Tool Works Inc. (ITW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Illinois Tool Works Inc. — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Illinois Tool Works Inc. trades at $264.13 (market cap $74.38B). The key difference: Illinois Tool Works Inc. is far larger — about 5.9× Halozyme Therapeutics Inc. Common Stock's market cap, and Illinois Tool Works Inc. pays a 2.63% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Illinois Tool Works Inc. for 67 Days on average.
| HALO | ITW | |
|---|---|---|
Market Cap | $12.58B | $74.38B |
Volume | 2,179,278 | 1,125,477 |
Sector | Health | Industrials |
52-Week High | $115.22 | $299.60 |
52-Week Low | $61.63 | $241.07 |
Typical Hold Time | 1 Days | 67 Days |
Enterprise Value | $14.49B | $83.23B |
Dividend Yield | — | 2.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ITW trades at $264.71, up 1.36% today, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $2.84, beating estimates, and maintains robust profitability with a 19.39% net income margin and 104.65% ROE. Recent news highlights its dividend increase to $1.72 per share and its status as a Dividend King with 59 years of consecutive increases.
The outlook is mixed: strong cash flow and dividend reliability support income investors, but high valuation ratios (P/E 23.65, P/B 25.7) and bearish technicals suggest near-term pressure. Risks include debt levels and sector volatility, while analyst consensus leans hold with a $276.86 price target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →
